product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Biglycan Protein, CF
catalog :
2667-CM-050
quantity :
50 ug
price :
394 USD
more info or order :
citations: 10
Reference
Gerhardy S, Ultsch M, Tang W, Green E, Holden J, Li W, et al. Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degeneration. Nat Commun. 2022;13:5222 pubmed publisher
Hoermann H, Krueger I, Maurus N, Reusswig F, Sun Y, Kohlmorgen C, et al. The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner. Int J Mol Sci. 2021;22: pubmed publisher
Bisson D, Sheng K, Kocabas S, Krock E, Teles A, Saran N, et al. Toll-like receptor involvement in adolescent scoliotic facet joint degeneration. J Cell Mol Med. 2020;24:11355-11365 pubmed publisher
Asega A, Menezes M, Trevisan Silva D, Cajado Carvalho D, Bertholim L, Oliveira A, et al. Cleavage of proteoglycans, plasma proteins and the platelet-derived growth factor receptor in the hemorrhagic process induced by snake venom metalloproteinases. Sci Rep. 2020;10:12912 pubmed publisher
Ferraro D, Patella F, Zanivan S, Donato C, Aceto N, Giannotta M, et al. Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells. BMC Cancer. 2019;19:312 pubmed publisher
Jongwattanapisan P, Terajima M, Miguez P, Querido W, Nagaoka H, Sumida N, et al. Identification of the effector domain of biglycan that facilitates BMP-2 osteogenic function. Sci Rep. 2018;8:7022 pubmed publisher
Mayer C, Adam M, Glashauser L, Dietrich K, Schwarzer J, Kohn F, et al. Sterile inflammation as a factor in human male infertility: Involvement of Toll like receptor 2, biglycan and peritubular cells. Sci Rep. 2016;6:37128 pubmed publisher
Rzeniewicz K, Newe A, Rey Gallardo A, Davies J, Holt M, Patel A, et al. L-selectin shedding is activated specifically within transmigrating pseudopods of monocytes to regulate cell polarity in vitro. Proc Natl Acad Sci U S A. 2015;112:E1461-70 pubmed publisher
Roy A, Ganesh G, Sippola H, Bolin S, Sawesi O, Dagälv A, et al. Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J Biol Chem. 2014;289:237-50 pubmed publisher
Kitaya K, Yasuo T. Dermatan sulfate proteoglycan biglycan as a potential selectin L/CD44 ligand involved in selective recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. J Leukoc Biol. 2009;85:391-400 pubmed publisher
product information
brand :
R&D Systems
master code :
2667-CM
SKU :
2667-CM-050
product name :
Recombinant Human Biglycan Protein, CF
description :
The Recombinant Human Biglycan Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Biglycan Protein, CF has been validated for the following applications: Bioactivity.
target :
Biglycan
category :
Proteins and Enzymes
unit sizes :
50 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
observed molecular weight :
40-45 kDa, reducing conditions
theoretical molecular weight :
38 kDa
gene symbol :
BGN
details of functionality :
Measured by its ability to inhibit the cell growth of mouse 3T3-L1 mouse embryonic fibroblast adipose-like cells. Ward, M. and Ajuwon, K.M. (2011) Cell Proliferation 44 :343. The ED50 for this effect is 1.5-6 µg/mL. Measured by its ability to increase the binding of BMP-4 to Chordin. Moreno, M. et al . (2005) EMBO J. 24 :1397. 2-8 µg/mL of Recombinant Human Biglycan will have a 50% maximum increase in the binding of recombinant human BMP-4 (0.1 µg/mL) to recombinant mouse Chordin (1 µg/mL).
endotoxin note :
<1.0 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
P21810
applications :
Bioactivity
source :
NS0-derived Recombinant Human Biglycan Protein, CF
USD :
394 USD
alt names :
BGN, biglycan, Bone/cartilage proteoglycan I, bone/cartilage proteoglycan-I, dermatan sulphate proteoglycan I, DSPG1, PGI, PG-S1, SLRR1A, SLRR1Abiglycan proteoglycan, small leucine-rich protein 1A
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.